SETD2 and cancer: This identified strong associations with the HIF-1 signalling pathway (p = 2.40E-11) for hESC, pathways in cancer (p≤0.000975) for hESC and hMSC, and cytokine-cytokine receptor interaction pathway (p = 0.001933) for hMSCs (Fig 7a and 7b and S4 and S5 Tables).